Mrs Joanne Davies
Teams and roles for Joanne Davies
Publication
2026
2025
2022
2021
2020
2019
2018
2017
2016
Articles
- Boldison, J. et al. 2026. CXCR3 expression on antigen experienced B-cells is systemically dysregulated in type 1
diabetes. Diabetologia 69 , pp.451-465. (10.1007/s00125-025-06608-y)
- Jenkins, B. J. et al., 2025. Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function. Nature Communications 16 (1) 9484. (10.1038/s41467-025-65417-4)
- Jenkins, B. et al., 2025. ABHD11 inhibition drives sterol metabolism to modulate T cell effector function 2 and alleviate autoimmunity. bioRxiv (10.1101/2025.03.19.643996)
- Boldison, J. et al. 2022. Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes. Diabetologia 66 (3), pp.551-566. (10.1007/s00125-022-05839-7)
- Boldison, J. et al. 2021. Natural protection from Type 1 Diabetes in Non obese diabetic (Nod) mice is characterised by a unique pancreatic islet phenotype. Diabetes 70 (3) db200945. (10.2337/db20-0945)
- Singh, R. K. et al. 2021. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides. Nanomedicine: Nanotechnology, Biology and Medicine 32 102321. (10.1016/j.nano.2020.102321)
- Thayer, T. C. et al. 2021. Differentiating MHC-dependent and -independent mechanisms of lymph node stromal cell regulation of Proinsulin-specific CD8+ T-Cells in type 1 diabetes. Diabetes 70 (2), pp.529-537. db191050. (10.2337/db19-1050)
- Boldison, J. et al. 2020. Dendritic cells license regulatory B cells to produce IL-10 and mediate suppression of antigen-specific CD8 T cells. Cellular and Molecular Immunology 17 , pp.843 - 855. (10.1038/s41423-019-0324-z)
- Hanna, S. J. et al. 2020. Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8+ T cells and exhibit a distinct CD95hi B cell phenotype. Diabetologia 63 , pp.1174-1185. Diabetologia volume 63, pages1174–1185(2020). (10.1007/s00125-020-05114-7)
- Boldison, J. et al. 2019. Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice. Diabetologia 62 (11), pp.2052-2065. (10.1007/s00125-019-04974-y)
- Pearson, J. A. et al. 2019. Altered gut microbiota activate and expand insulin B15-23-Reactive CD8+ T-Cells. Diabetes 68 (5), pp.1002-1013. (10.2337/db18-0487)
- Powell, W. E. et al. 2018. Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes. Diabetologia 61 , pp.1794-1803. (10.1007/s00125-018-4651-x)
- Da Rosa, L. C. et al., 2018. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model. Diabetologia 61 (6), pp.1397-1410. (10.1007/s00125-018-4597-z)
- Fishman, S. et al., 2017. Adoptive transfer of mRNA-Transfected T cells redirected against diabetogenic CD8 T cells can prevent diabetes. Molecular Therapy 25 (2), pp.456-464. (10.1016/j.ymthe.2016.12.007)
- Pearson, J. A. et al. 2016. Proinsulin expression shapes the TCR repertoire but fails to control the development of low-avidity insulin-reactive CD8+ T cells. Diabetes 65 (6), pp.1679-1689. (10.2337/db15-1498)